De nos jours, les matériaux carbonés macroscopiques font face à un nombre croissant d'applications en catalyse, soit en tant que supports, soit directement en tant que catalyseurs sans métal. Cependant, il reste difficile de développer un support de catalyseur hiérarchisé à base de. carbone ou un catalyseur utilisant un procédé de synthèse beaucoup plus simple. À la recherche de nouveaux matériaux carbonés structurés pour la catalyse hétérogène, nous avons exploré le potentiel du feutre de carbone / graphite du commerce (FC / FG). Le but du travail décrit dans cette thèse a été le développement du monolithe FG et FC en tant que catalyseur sans métal pour les réactions d’oxydation en phase gazeuse et en tant que support de catalyseur, notamment pour le palladium, pour les réactions d’hydrogénation en phase liquide, et leur rôle dans la performance de réaction de ces catalyseurs. En raison de leur surface de chimie inerte avec une mouillabilité inappropriée, une telle étude avait pour condition d'activer celles d'origine. Par conséquent, des FG et des FC modifiés bien arrondis ont été synthétisés avec des propriétés physico-chimiques adaptées par une série de procédés de traitement chimique, tels que l'oxydation, l'amination, la thiolation, le dopage à l'azote et au soufre. L’oxydation partielle du sulfure d’hydrogène en soufre élémentaire et l’hydrogénation sélective du cinnamaldéhyde α, β-insaturé, en tant que réactions sensibles à l’effet des propriétés du catalyseur sur l’activité et la sélectivité, combinées à des techniques de caractérisation, ont été choisis pour étudier l’effet de la matériaux carbonés sur le comportement catalytique. / Nowadays, macroscopic carbon materials are facing an increasing number of applications in catalysis, either as supports or directly as metal-free catalysts on their own. However, it is still challenging to develop hierarchical carbon-based catalyst support or catalyst using a much simple synthesis process. In the quest for novel structured carbon materials for heterogeneous catalysis we explored the potential of commercial carbon/graphite felt (CF/GF). The aim of the work described in this thesis has been the development of GF and CF monolith as metal-free catalyst for gas-phase oxidation reactions and as catalyst support, notably for palladium, for liquid-phase hydrogenation reactions, and their roles in the reaction performance of these catalysts. Due to their inert chemistry surface with inappropriate wettability, a prerequisite for such a study was to activate the origin ones. Therefore, well-rounded modified GFs and CFs were synthesized with tailored physic-chemical properties by a series of chemical treatment processes, such as oxidation, amination, thiolation, nitrogen- and sulfur-doping. The partial oxidation of hydrogen sulfide into elemental sulfur and selective hydrogenation of α, β-unsaturated cinnamaldehyde, as the sensitive test reactions to the influence of the catalyst properties on activity and selectivity, combined with characterization techniques, were chosen to investigate the effect of functionalized carbon materials on the catalytic behavior.

Interstitial brachytherapy using permanent seeds is a common modality for the treatment of early stage prostate cancer. It consists of inserting hundreds of radioactive seeds (size of a grain of rice) in the prostate by means of transperineal needles. In this procedure, dose delivery to healthy surrounding organs at risk (OAR) and dose homogeneity within the prostate are of prime concern. Placement errors should therefore be minimized to avoid unacceptable area underdosage or overdosage. At present, brachytherapy seeds can be loaded with three different radionuclides: iodine-125 (¹²⁵I: 28.37 keV; 59.40 days), palladium-103 (¹⁰³Pd: 20.74 keV; 16.991 days), and cesium-131 (¹³¹Cs: 30.45 keV; 9.689 days). Long or short term morbidity is the main drawback of ¹²⁵I and ¹³¹Cs due to their deeper penetration in the normal tissues. However, both provide a good homogeneity of the dose distribution within the prostate. By contrast, ¹⁰³Pd offers a short penetration depth that reduces the dose to OAR. Nevertheless, it could result in cold spot (underdosage) where a recurrence of the cancer could appear. A compromise had to be found between good implant uniformity and low dose to OAR. We propose therefore to study if the combination of two radionuclides inside the same seed could be a solution. Two mixtures were considered: ¹⁰³Pd_0.75-¹²⁵I_0.25 and ¹⁰³Pd_0.25-¹³¹Cs_0.75. The subscripts denote the fractions of internal activity of each radionuclide. The work is subdivided into three steps. First we adapt the AAPM TG-43U1 dosimetry formalism used by the physician to make multiple-radionuclides sources compatible with Treatment Planning Systems (TPS). Then the dose distributions around the bi-radionuclide seeds are determined. Second, the prescription doses for both sources are derived using the linear quadratic model for tumor cell surviving fraction. They were computed using mono-radionuclide implants as benchmarks. Finally, treatment plans and Dose-Volume Histograms parameters have been computed on real patients virtually implanted with bi-radionuclide seeds and the results were compared with the mono-radionuclide one. These parameters can then be used to evaluate the Normal Tissue Complication Probability (NTCP) of urethra, the most exposed organ at risk in prostate brachytherapy. First, dosimetry results show that, from a pure physical point of view (i.e. without tissue reponse), the dose distributions of both mixtures lies in between that for ¹⁰³Pd and ¹²⁵I/¹³¹Cs. The compromise between homogeneity and reduced dose at large distance can be reached. Second, the averaged prescription doses for the Pd-I mixture are 142⁺¹⁵_-16Gy and 142⁺⁶_-8Gy using ¹⁰³Pd and ¹²⁵I as benchmarks, respectively. The values for the Pd Cs mixture are 128⁺¹³_-13Gy and 115⁺⁶_-7Gy, using ¹⁰³Pd and ¹³¹Cs, respectively, as benchmarks. Finally, urethral NTCP results fall in the 19 to 23% range. However, they are affected by large uncertainties, making the comparison difficult. At present, no conclusion could be drawn about the efficiency of bi-radionuclide brachytherapy in comparison with mono-radionuclide using the available models. Permanent seed prostate brachytherapy suffers a lot from the lack of precision on radiobiological modelling parameters. A better knowledge of their values could significantly improve the predicting models and therefore lead to better treatment outcome.

Questa tesi presenta un’indagine sugli attivisti del Partito Democratico, condotta tra il 2009 e il 2010 nei circoli di quattro città italiane (Milano, Perugia, Roma e Napoli) attraverso etnografie e interviste biografiche. L’identità degli attivisti è studiata attraverso il metodo dello storytelling, ampiamente utilizzato negli studi dei fenomeni politici. Partendo dal presupposto teorico che ogni attivista possiede tante identità quanti sono i suoi flussi stabili di relazioni verso altri attori (individuali o collettivi), ne vengono individuati essenzialmente due: il primo verso l’interno dell’organizzazione e il secondo verso l’esterno. Nel primo caso, l’identità degli attivisti viene studiata attraverso le relazioni che essi intrattengono all’interno del partito (con leader, dirigenti e altri attivisti). Nel secondo caso, vengono analizzate le relazioni che gli attivisti intrattengono con elettori e realtà associative dei territori. Infine, si presenteranno gli aspetti dinamici delle identità degli attivisti, le scintille del mutamento che attraversano le loro storie. Il quadro generale che emerge dalla ricerca è un attivismo che viene definito, con una metafora informatica, “1.5”: un attivismo contemporaneo che sta esperendo un mutamento dalla militanza tradizionale dei partiti elettorali di massa, in una direzione che però è ancora per molti aspetti nebulosa. Un mutamento incompiuto: una rivoluzione “1.5”. / This work presents field research on the activists of the Italian Democratic Party, developed between 2009 and 2010 in four Italian cities (Milan, Perugia, Rome and Naples) through ethnographies and in-depth interviews. The identity of the activists is studied through the method of storytelling, widely used within the field of political studies. Starting from the theoretical assumption that social identities are stable steams of relations between actors, this work identifies two relevant steams for party activists: the first is toward the organization itself, and the second is toward the territory. In the first case, the identity of the activists is examined through the relationships with party leaders, managers and other activists. In the second case, it is analyzed the relation that activists maintain with the territory: voters, associations, and other political organizations. Finally, it is presented the dynamic aspect of the activists’ identities, the spark of change that run through their stories. The overall picture that emerges from the research is a “1.5 activism”: a contemporary form of activism that is experiencing a shift from traditional electoral mass parties, yet still remaining unfinished. A “1.5” revolution.

Die Arbeit behandelt Methoden zur Analyse bzw. Synthese elektromechanischer Systeme mit endlichem Freiheitsgrad (EMS). Dabei wird von einer einheitlichen mathematischen Modellierung solcher Systeme basierend auf dem Prinzip der virtuellen Arbeit in Lagrange'scher Fassung ausgegangen. Als Analysemethoden für strukturfeste EMS werden neben der numerischen Integration die Bestimmung von Gleichgewichtszuständen und die Herleitung der linearisierten Gleichungen zur Schwingungsanalyse dargelegt. Auf die Analyse von strukturvariablen EMS wird ausführlich eingegangen. Dazu werden Phänomene der Strukturvariabilität domänenunabhängig als unilaterale Bindungen aufgefasst und mittels komplementärer Variablen beschrieben. Die kombinatorische Aufgabe der Strukturfindung wird mittels eines linearen Komplementaritätsproblems gelöst. Die Synthese eines EMS wird als inverses Problem der Dynamik aufgefasst. Bei fester Gesamtkonfiguration führt das auf die nichtlineare dynamische Steuerung solcher Systeme. Dazu wird ein so genannter erweiterter PD-Regler - bestehend aus einer nichtlinearen Vorsteuerung auf Basis der inversen Dynamik des EMS und einer linearen Rückführung des Lage- und Geschwindigkeitsfehlers - entworfen. Die globale asymptotische Stabilität dieses Regelgesetzes wird durch explizite Konstruktion einer Lyapunov-Funktion nachgewiesen. Einige Beispiele zur Anwendung der aufgeführten Analyse- und Synthesemethoden runden die Arbeit ab. The thesis deals with methods for analysis and synthesis of electromechanical systems with finite degrees of freedom (EMS). Starting point is a unified mathematical approach to modelling such systems based on the principle of virtual work in Lagrange's formulation. Numerical integration, determination of equilibrium states and derivation of linearized equations are used as analytical methods for EMS with fixed structure. Electromechanical systems with variable structure are regarded explicitly. Phenomena of structural variability are comprehended as unilateral constraints and described using complementary variables. The combinatorial task of finding a valid structure is solved using a linear complementarity problem. The synthesis of EMS is understood as an inverse task of dynamics. Using a fixed configuration, this approach leads to non-linear dynamic control of such systems. A so-called augmented PD-controller - consisting, on the one hand, of a non-linear feedforward based on inverse dynamics of the EMS and, on the other hand, of a linear feedback using position and velocity errors - is designed. Global asymptotic stability is proven by explicit construction of a Lyapunov-function. Some examples showing the usage of the corresponding analytical and synthetic methods are given.

A recent model of Parkinson’s disease (PD) suggests that the neuropathological, behavioural and cognitive symptoms progress in stages. There is substantial evidence for a prodromal stage of PD, during which time pre-motor symptoms develop. Rapid eye movement (REM) sleep behaviour disorder (RBD) is a risk factor for developing PD and may be part of the pre-motor stage. In both disorders, neuropathological α-synuclein aggregates are thought to be a direct cause of the resulting symptoms. One model has shown that in rats, proteasome inhibition produced by systemic exposure to environmental toxins results in α-synuclein pathology and motor behaviour dysfunction that mimics the progression of PD in humans. The present study examined the hypothesis that the systemic proteasome inhibition model would produce pre-Parkinsonian RBD-like pathology in rats. It was expected that sleep disturbances would be seen prior to behavioural disturbances in rats treated systemically with PSI (a proteasome inhibitor). Following baseline sleep recording and training on the inclined beam-traverse task, rats were injected with PSI (a proteasome inhibitor) or ethanol (control), 6 times over 2 wk. Sleep recording over 8 wk and behavioural testing over 16 wk provided no evidence of sleep disturbances or motor dysfunction. Post-mortem immunohistochemical analyses of brain tissue provided no evidence of PSI-associated α-synuclein aggregates in the locus coeruleus, subcoeruleus (dorsal part), or substantia nigra (areas involved in RBD and/or PD). These results did not provide support for RBD as a prodromal phase of PD within the systemic proteasome inhibitor-based model and add to a growing body of research reporting inconsistent findings using this model. We suggest that systemic PSI exposure in rats does not produce a viable model of RBD or PD. Whether RBD is an early symptom in the progression of PD remains to be established. / Thesis (Master, Neuroscience Studies) -- Queen's University, 2010-04-28 12:04:50.613

No description available.

Accurate self-report assessment of psychopathology depends on individuals responding honestly and accurately. Some respondents, however, may respond in a manner not representative of their traits/symptoms. The MMPI-2-RF contains “validity” scales to detect elevations on over-reporting (OR) or under-reporting (UR) scales which typically correspond to elevations on MMPI-2-RF substantive scales and on instruments administered alongside the MMPI-2-RF. We examined effects of OR and UR on the Personality Inventory for DSM-5 (PID-5); a self-report instrument that assesses 25 pathological traits used with other diagnostic criteria to diagnose personality disorders (PDs) in Section III of the DSM-5. Using MMPI-2-RF validity scale scores, 908 students and 255 psychiatric outpatients were classified into OR, UR or within normal limit response groups. Significant group differences were found such that differences in the frequency of PD diagnosis emerged across response groups. We believe the PID-5 is vulnerable to OR and UR responding, which potentially compromises its validity.

Accurate self-report assessment of psychopathology depends on individuals responding honestly and accurately. Some respondents, however, may respond in a manner not representative of their traits/symptoms. The MMPI-2-RF contains “validity” scales to detect elevations on over-reporting (OR) or under-reporting (UR) scales which typically correspond to elevations on MMPI-2-RF substantive scales and on instruments administered alongside the MMPI-2-RF. We examined effects of OR and UR on the Personality Inventory for DSM-5 (PID-5); a self-report instrument that assesses 25 pathological traits used with other diagnostic criteria to diagnose personality disorders (PDs) in Section III of the DSM-5. Using MMPI-2-RF validity scale scores, 908 students and 255 psychiatric outpatients were classified into OR, UR or within normal limit response groups. Significant group differences were found such that differences in the frequency of PD diagnosis emerged across response groups. We believe the PID-5 is vulnerable to OR and UR responding, which potentially compromises its validity.

Abstract: Neurodegenerative diseases are associated with progressive loss of structure or function of neurons which results in cell death. Recent evidence indicate that all neurodegenerative disorders, sporadic or transmissible, may have a common pathological mechanism at the molecular level. This common feature consists of protein aggregation and accumulation of harmful aggregates in neuronal cells resulting in cellular apoptosis and neurotoxicity. Neurodegenerative diseases can affect abstract thinking, skilled movements, emotional feelings, cognition, memory and other abilities. This diverse group of diseases includes Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), prion diseases or transmissible spongiform encephalopathies (TSEs) and amyotrophic lateral sclerosis. In my project I worked on the molecular mechanism of protein aggregation, propagation and neurotoxicity in Parkinson's disease and prion disease. Prion disease and PD are associated with misfolding and aggregation of PrPc and a-Synuclein (a-Syn), respectively. Despite being two important neurodegenerative disorders, molecular mechanisms of a-Syn or PrPC aggregation and amyloidogenesis are still unclear in PD and prion disease. Furthermore, the toxic protein species in PD have not been characterized yet. In this study we characterize the mechanism of a-Syn and PrPc misfolding in a physiological-like cell free condition in the absence of a-Syn aggregates, PrPc ggregated isoform (Pre's), denaturants or acidic environment. A number of studies indicate that dimerization of PrPc or a-Syn may be a key step in the aggregation process. To test this hypothesis we verified if enforced dimerization of PrPc or a-Syn may induce a conformational change reminiscent of the conversion of PrPc or a-Syn to PrPR' or a-Syn aggregates, respectively. We used a well-described inducible dimerization strategy where a dimerizing domain called FK506-binding protein (Fv) was fused to PrPc or a-Syn in order to produce chimeric proteins Fv-PrP and a-SynF'''. A divalent ligand AP20187 was used to induce protein dimerization. Addition of AP20187 to recombinant Fv-PrP in physiological-like conditions resulted in a rapid conformational change characterized by an increase in beta-sheet (13-Sheet) structure and simultaneous aggregation of the proteins. However, non-dimerized PrP formed 13-Sheet conformation in very slower rates. In the presence of AP20187, we also report a rapid random coil into 13-sheet conformational transformation of a-SynF" within 24 h, whereas wild type a-Syn showed 24 h delay to achieve P-sheet structure after 48 h. Electron microscopy experiments demonstrated that dimerization induced amyloid fibril formation after 48 h for both Fv-PrP and a-Syr?", whereas in the absence of dimerizing ligand AP20187, PrP or a-Syn converted into amyloid fibrils after 3 days or even later. Dimerization-induced Fv-PrP aggregates were partially resistant to PK digestion which is a characteristics of the naturally occurring PrPR'. The rates of amyloidogenesis in the presence of dimerization was also characterized by Thioflavin T (ThT) fluorescence probing. Whereas the stable structure of Fv-PrP showed no ThT binding for over 60 h of incubation at 37°C, the addition of AP20187 to Fv-PrP resulted in a time-dependent increase in ThT binding. As for a-SynR, dimerization accelerated the rate of ThT binding and amyloid formation comparing to the slower amyloidogenesis rate of wild type a-Syn in the absence of dimerizer AP20187. The impact of dimerization on a-Syn aggregation was further determined by Fluorescence ANS probing, indicating a higher affinity of dimerization-induced a-SynF" aggregates for binding to ANS comparing to wild type a-Syn aggregates. These results indicate that dimerization increases the aggregation and amyloidogenesis processes for Fv-PrP and a-SynF". Both Fv-PrP and a-SynF" amyloids were successfully propagated in vitro by protein misfolding amplification (PMCA) cycle. These results ar in agreement with the theory that all protein aggregates in neurodegenerative diseases propagate with the same molecular mechanism. Neurotoxicity of recombinant Fv-PrP and a-SynF" aggregates was determined in cellulo and in vivo, respectively. Aggregates of Fv-PrP were toxic to cultured cells whilst soluble Fv-PrP and amyloid fibres were harmless to the cells. When injected to the mice brain, both a-Syni" and a-Syn pre-fibrillar aggregates internalized cells and induced neurotoxicity in the hippocampus of wild-type mice. These recombinant toxic aggregates further converted into non-toxic amyloids which were successfully amplified by PMCA method, providing the first evidence for the in vitro propagation of synthetic a-Syn aggregates. These results suggest an important role for protein dimerization in aggregation and amyloidogenesis, and therefore, in the pathology of PD and prion disease. The similarities between aggregation, amyloidogenesis and toxicity of PrPC and ct-Syn provide further evidence on the existance of a prion-like mechanism in all neurodegenerative disorders. // Résumé: Les maladies neurodégénératives sont associées à la perte progressive des propriétés structurales ou fonctionnelles des neurones, ce qui engendre la mort des cellules. De récentes études indiquent que tous les désordres neurodégénératifs, sporadiques ou transmissibles, peuvent avoir un mécanisme pathologique commun au niveau moléculaire. Ce dispositif commun se compose de l'agrégation de protéines, de la propagation des agrégats, et de l'accumulation d’agrégats toxiques dans les cellules neuronales, menant à l'apoptose et à la neurotoxicité cellulaire. Les maladies neurodégénératives peuvent affecter la pensée abstraite, les mouvements habiles, les sentiments émotifs, la connaissance, la Mémoire et d'autres capacités cognitives. Ce groupe divers de maladies inclut la maladie d'Alzheimer (AD), de Parkinson (PD), de Huntington (HD), les maladies à prions ou encéphalopathies spongiformes transmissibles (TSEs) et la sclérose latérale amyotrophique (ALS). [symboles non conformes]

Cette thèse est consacrée à la modélisation mathématique de l'hématopoïèse et des maladies sanguines. Plusieurs modèles traitant d'aspects différents et complémentaires de l'hématopoïèse y sont étudiés.Tout d'abord, un modèle multi-échelle de l'érythropoïèse est analysé, dans lequel sont décrits à la fois le réseau intracellulaire, qui détermine le comportement individuel des cellules, et la dynamique des populations de cellules. En utilisant des données expérimentales sur les souris, nous évaluons les rôles des divers mécanismes de retro-contrôle en réponse aux situations de stress.Ensuite, nous tenons compte de la distribution spatiale des cellules dans la moelle osseuse, question qui n'avait pas été étudiée auparavant. Nous décrivons l'hématopoïèse normale à l'aide d'un système d'équations de réaction-diffusion-convection et nous démontrons l'existence d'une distribution stationnaire des cellules. Puis, nous introduisons dans le modèle les cellules malignes. Pour certaines valeurs des paramètres, la solution "disease-free" devient instable et une autre solution, qui correspond à la leucémie, apparaît. Cela mène à la formation d'une tumeur qui se propage dans la moelle osseuse comme une onde progressive. La vitesse de cette propagation est étudiée analytiquement et numériquement. Les cellules de la moelle osseuse échangent des signaux qui régulent le comportement cellulaire. Nous étudions ensuite une équation integro-différentielle qui décrit la communication cellulaire et nous prouvons l'existence d'une solution du type onde progressive en utilisant la théorie du degré topologique et la méthode de Leray et Schauder. L'approche multi-agent est utilisée afin d'étudier la distribution des différents types de cellules dans la moelle osseuse.Finalement, nous étudions un modèle de type "Physiologically Based Pharmacokinetics-Pharmacodynamics" du traitement de la leucémie par l'AraC. L'AraC agit comme chimiothérapie et induit l'apoptose de toutes les cellules proliférantes, saines et malignes. La pharmacocinétique donne accès à la concentration intracellulaire d'AraC. Cette dernière, à son tour, détermine la dynamique des populations cellulaires et, par conséquent, l'efficacité de différents protocoles de traitement.